Clinical Tech Leader的动态

Staying Ahead with Medical Innovations ? While leading in clinical trials, 3SYNC Research is also keenly aware of emerging medical breakthroughs, such as the new AI-generated COVID drug now entering Phase I trials. Promising to be effective against all variants, this oral medication could soon offer a significant alternative to current treatments. It's a testament to our commitment to staying at the forefront of healthcare advancements. Learn more about this promising development here: 3sync.com 1-800-733-7962 #MedicalInnovation #COVID19Research #3SYNCResearch

How can we unlock the potential of digitizing clinical trials, accelerating research and improving the experience for patients and sites? In collaboration with Transcelerate, my colleague Kelsey Jakee sheds light on the incremental steps companies can take to bring about positive change #ClinicalTrials #DigitalTransformation #PharmaInnovation

?? New Blog Post: FDA Guidance on Diversity in Clinical Trials Discover how the FDA's guidance is paving the way for more inclusive and representative clinical trials. Our latest post explores key strategies and the importance of diversity in clinical research. ?? Read the full blog post here: https://bit.ly/3x2Y7vY

Hi everyone! This is a blog post you do not want to miss! It is a comprehensive view of the FDA guidance focused on trial design approaches like flexible visit windows and use of digital health technologies. What do you think is coming next from the FDA about diversity? #inclusiveclinicaltrials #clinicalresearch #clinicaltrials

Let's re-think how we target and recruit patients ?? Let's re-think how we keep patients enrolled in clinical trials ?? #diversity #clinicaltrials #clinicalresearch

Check out this blog post I co-wrote with Marc Wartenberger!

Bridging the gap between Drug Development and then getting the medicine into the hands of patients.... Our experts Amanda Bruno and Angela Wlodar explore how medical science liaisons (MSLs) bridge the gap between R&D teams and commercial teams, the challenges in quantifying MSLs value, how their role is expanding and more. Learn more in their PM360 article: https://ow.ly/bCaF30sBZU0 #SyneosHealth

Wondering why your CRO is suggesting an adaptive clinical trial? As the name suggests, an adaptive design allows for more flexibility, which can be especially useful if there are uncertainties specific to your drug. Being able to change the course of your study as data accumulates means getting crucial answers sooner—saving you both time and money. Dr. Gaetano Morelli, Chief Medical Officer, shares more insight on adaptive clinical trials at Altasciences. #WeAreAltasciences #DrugDevlopment #ClinicalResearch

Clinical-translational studies are essential in the validation of medical and diagnostic devices. These studies are pivotal in transitioning diagnostic technologies from the laboratory to clinical practice. By evaluating diagnostic accuracy, clinical utility, and compliance with regulatory guidelines, these studies ensure that new diagnostic tools are effective and reliable in real-world settings. Discover how clinical-translational studies contribute to advancing medical diagnostics and improving patient outcomes in our blog post. Read more here: https://lnkd.in/eFke85nf #ClinicalResearch #DiagnosticDevices #Biostatistics #HealthcareInnovation #AnatomiseBiostats #ClinicalTranslationalStudies

Digitising clinical trials has the potential to accelerate clinical research and improve patient and site experience. But with many digitisation efforts in healthcare, how do you do it without further worsening the digital divide? My colleague, Kelsey Jakee, alongside Transcelerate, explains how companies can take small steps to realise positive change. #ClinicalTrials #DCTs #DecentralizedTrials #PharmaInnovation